Synopsys (NASDAQ:SNPS) closed at $462.88. The 24/7 Wall St. price target of $600.25 means 29.68% upside over the next 12 months. The stock earns a buy rating with 90% confidence.
.24/7 Wall St. 24/7 Wall St. Price Target Summary Metric Value Current Price $462.88 Price Target from 24/7 Wall St. $600.25 Upside 29.68% Recommendation BUY Confidence Level 90%
The stock has gone sideways this year even as the business picked up speed. Management raised fiscal 2026 guidance to $9.690B to $9.740B in revenue and $15.04 to $15.10 in non-GAAP EPS.
AI design starts keep speeding up, Ansys is adding scale, and Design IP is growing again. I think the market still values Synopsys like a mature EDA vendor.
Record Quarter, Flat Stock: Synopsys Shares Trail the FundamentalsShares are down 1.46% over the past week, down 4.57% over the past month and down 0.47% year to date. The 52-week range runs from $362.55 to $539.48. In the fiscal third quarter, revenue rose 42.4% to $2.48B and came in ahead of estimates. Non-GAAP EPS of $3.91 also beat the $3.67 consensus. That was the company’s fourth straight beat.
Since then, Synopsys has announced GPT-Synopsys with OpenAI, a multi-year custom-silicon IP agreement with Amazon (NASDAQ:AMZN) and an agentic AI partnership with TSMC (NYSE:TSM). It also started a $1 billion speeding up share repurchase.
Why Bulls See $689 AheadManagement says Multiphysics Fusion, which combines Synopsys and Ansys technology, will start adding to EDA growth in 2027. The company has more than 30 active agentic AI customer projects. Synopsys also won more than 95% of PCIe 7 opportunities. Its Factory 2 model adds royalties on top of licensing fees.
CEO Sassine Ghazi says that autonomous design adds demand for Synopsys tools: “You still need the ground truth physics in order for that model to be able to operate with confidence.”
Among analysts, 23 are bullish on the stock and 2 rate it a Hold. Their consensus target is $586.95. The bull case goes to $689.12.
Debt, China and Integration Risks Worth WatchingTotal debt stands near $10 billion. Guidance assumes no further export-control or Entity List changes. Organic EDA growth slowed to 8.5% in Q3, and a Morgan Stanley downgrade earlier this year highlighted deceleration risk. Several factors offset these risks.
The Q3 figure came against a 16% comparison quarter. Synopsys also repaid its term loans early and expects about $2.6B in free cash flow. The bear case sets the stock at $518.06.
How Synopsys Compares to Cadence and AutodeskCadence Design Systems (NASDAQ:CDNS) is Synopsys’ closest EDA rival and has a similar market value of $88.8B. Its revenue grew 21.99%, and it guides to non-GAAP operating margins of 44.2% to 45.2%. Cadence has the stronger organic growth. Synopsys offers more room for margin gains as Ansys synergies arrive.
Autodesk (NASDAQ:ADSK) gives a reference point for the simulation and design software that Ansys added. Autodesk grew revenue 16.05% and guides to a non-GAAP margin of about 39%, both below Synopsys. Across this group, Synopsys posts the fastest revenue growth.
Company Market Cap Latest Revenue Growth FY Non-GAAP Op. Margin Guide Synopsys $88.7B 42.4% ~41.5% Cadence $88.8B 21.99% 44.2% to 45.2% Autodesk $52.7B 16.05% ~39% Upside Outweighs the Risk Near $463The 24/7 Wall St. price target of $600.25 comes with a buy rating and 90% confidence. Even the bear case stands above today’s price, which is what persuades me.
I would grow more constructive if EDA growth returns to double digits in Q4 as guided. I would turn more conservative if export rules tighten or the Ansys synergies fall through. On balance, I think the reward outweighs the risk.
If current growth trends continue, here is where our model projects the stock could trade.
Year Price Target from 24/7 Wall St. 2026 $475.44 2027 $600.25 2028 $714.22 2029 $832.46 2030 $887.59The projections rest on Synopsys continuing its current strategy. Royalty-based custom silicon deals could push results higher, while new China restrictions could weigh on them.